Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients

Given the immune system's importance for cancer surveillance and treatment, we have investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some heterogeneity in tumor type, stage, and treatment, virus-exposed solid cancer patients display a dominant impact of SAR...

Full description

Bibliographic Details
Main Authors: Abdul-Jawad, S, Baù, L, Alaguthurai, T, Del Molino Del Barrio, I, Laing, AG, Hayday, TS, Monin, L, Muñoz-Ruiz, M, McDonald, L, Francos Quijorna, I, McKenzie, D, Davis, R, Lorenc, A, Chan, JNE, Ryan, S, Bugallo-Blanco, E, Yorke, R, Kamdar, S, Fish, M, Zlatareva, I, Vantourout, P, Jennings, A, Gee, S, Doores, K, Bailey, K, Hazell, S, De Naurois, J, Moss, C, Russell, B, Khan, AA, Rowley, M, Benjamin, R, Enting, D, Alrifai, D, Wu, Y, Zhou, Y, Barber, P, Ng, T, Spicer, J, Van Hemelrijck, M, Kumar, M, Vidler, J, Lwin, Y, Fields, P, Karagiannis, SN, Coolen, ACC, Rigg, A, Papa, S, Hayday, AC, Patten, PEM
Format: Journal article
Language:English
Published: Cell Press 2021
_version_ 1797108120897454080
author Abdul-Jawad, S
Baù, L
Alaguthurai, T
Del Molino Del Barrio, I
Laing, AG
Hayday, TS
Monin, L
Muñoz-Ruiz, M
McDonald, L
Francos Quijorna, I
McKenzie, D
Davis, R
Lorenc, A
Chan, JNE
Ryan, S
Bugallo-Blanco, E
Yorke, R
Kamdar, S
Fish, M
Zlatareva, I
Vantourout, P
Jennings, A
Gee, S
Doores, K
Bailey, K
Hazell, S
De Naurois, J
Moss, C
Russell, B
Khan, AA
Rowley, M
Benjamin, R
Enting, D
Alrifai, D
Wu, Y
Zhou, Y
Barber, P
Ng, T
Spicer, J
Van Hemelrijck, M
Kumar, M
Vidler, J
Lwin, Y
Fields, P
Karagiannis, SN
Coolen, ACC
Rigg, A
Papa, S
Hayday, AC
Patten, PEM
author_facet Abdul-Jawad, S
Baù, L
Alaguthurai, T
Del Molino Del Barrio, I
Laing, AG
Hayday, TS
Monin, L
Muñoz-Ruiz, M
McDonald, L
Francos Quijorna, I
McKenzie, D
Davis, R
Lorenc, A
Chan, JNE
Ryan, S
Bugallo-Blanco, E
Yorke, R
Kamdar, S
Fish, M
Zlatareva, I
Vantourout, P
Jennings, A
Gee, S
Doores, K
Bailey, K
Hazell, S
De Naurois, J
Moss, C
Russell, B
Khan, AA
Rowley, M
Benjamin, R
Enting, D
Alrifai, D
Wu, Y
Zhou, Y
Barber, P
Ng, T
Spicer, J
Van Hemelrijck, M
Kumar, M
Vidler, J
Lwin, Y
Fields, P
Karagiannis, SN
Coolen, ACC
Rigg, A
Papa, S
Hayday, AC
Patten, PEM
author_sort Abdul-Jawad, S
collection OXFORD
description Given the immune system's importance for cancer surveillance and treatment, we have investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some heterogeneity in tumor type, stage, and treatment, virus-exposed solid cancer patients display a dominant impact of SARS-CoV-2, apparent from the resemblance of their immune signatures to those for COVID-19+ non-cancer patients. This is not the case for hematological malignancies, with virus-exposed patients collectively displaying heterogeneous humoral responses, an exhausted T cell phenotype and a high prevalence of prolonged virus shedding. Furthermore, while recovered solid cancer patients' immunophenotypes resemble those of non-virus-exposed cancer patients, recovered hematological cancer patients display distinct, lingering immunological legacies. Thus, while solid cancer patients, including those with advanced disease, seem no more at risk of SARS-CoV-2-associated immune dysregulation than the general population, hematological cancer patients show complex immunological consequences of SARS-CoV-2 exposure that might usefully inform their care.
first_indexed 2024-03-07T07:23:07Z
format Journal article
id oxford-uuid:98e6ccc9-a446-4543-8220-de65ab0f3732
institution University of Oxford
language English
last_indexed 2024-03-07T07:23:07Z
publishDate 2021
publisher Cell Press
record_format dspace
spelling oxford-uuid:98e6ccc9-a446-4543-8220-de65ab0f37322022-11-08T11:38:53ZAcute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patientsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:98e6ccc9-a446-4543-8220-de65ab0f3732EnglishSymplectic ElementsCell Press2021Abdul-Jawad, SBaù, LAlaguthurai, TDel Molino Del Barrio, ILaing, AGHayday, TSMonin, LMuñoz-Ruiz, MMcDonald, LFrancos Quijorna, IMcKenzie, DDavis, RLorenc, AChan, JNERyan, SBugallo-Blanco, EYorke, RKamdar, SFish, MZlatareva, IVantourout, PJennings, AGee, SDoores, KBailey, KHazell, SDe Naurois, JMoss, CRussell, BKhan, AARowley, MBenjamin, REnting, DAlrifai, DWu, YZhou, YBarber, PNg, TSpicer, JVan Hemelrijck, MKumar, MVidler, JLwin, YFields, PKaragiannis, SNCoolen, ACCRigg, APapa, SHayday, ACPatten, PEMGiven the immune system's importance for cancer surveillance and treatment, we have investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some heterogeneity in tumor type, stage, and treatment, virus-exposed solid cancer patients display a dominant impact of SARS-CoV-2, apparent from the resemblance of their immune signatures to those for COVID-19+ non-cancer patients. This is not the case for hematological malignancies, with virus-exposed patients collectively displaying heterogeneous humoral responses, an exhausted T cell phenotype and a high prevalence of prolonged virus shedding. Furthermore, while recovered solid cancer patients' immunophenotypes resemble those of non-virus-exposed cancer patients, recovered hematological cancer patients display distinct, lingering immunological legacies. Thus, while solid cancer patients, including those with advanced disease, seem no more at risk of SARS-CoV-2-associated immune dysregulation than the general population, hematological cancer patients show complex immunological consequences of SARS-CoV-2 exposure that might usefully inform their care.
spellingShingle Abdul-Jawad, S
Baù, L
Alaguthurai, T
Del Molino Del Barrio, I
Laing, AG
Hayday, TS
Monin, L
Muñoz-Ruiz, M
McDonald, L
Francos Quijorna, I
McKenzie, D
Davis, R
Lorenc, A
Chan, JNE
Ryan, S
Bugallo-Blanco, E
Yorke, R
Kamdar, S
Fish, M
Zlatareva, I
Vantourout, P
Jennings, A
Gee, S
Doores, K
Bailey, K
Hazell, S
De Naurois, J
Moss, C
Russell, B
Khan, AA
Rowley, M
Benjamin, R
Enting, D
Alrifai, D
Wu, Y
Zhou, Y
Barber, P
Ng, T
Spicer, J
Van Hemelrijck, M
Kumar, M
Vidler, J
Lwin, Y
Fields, P
Karagiannis, SN
Coolen, ACC
Rigg, A
Papa, S
Hayday, AC
Patten, PEM
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
title Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
title_full Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
title_fullStr Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
title_full_unstemmed Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
title_short Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
title_sort acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus 2 infected cancer patients
work_keys_str_mv AT abduljawads acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT baul acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT alaguthurait acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT delmolinodelbarrioi acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT laingag acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT haydayts acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT moninl acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT munozruizm acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT mcdonaldl acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT francosquijornai acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT mckenzied acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT davisr acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT lorenca acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT chanjne acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT ryans acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT bugalloblancoe acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT yorker acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT kamdars acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT fishm acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT zlatarevai acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT vantouroutp acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT jenningsa acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT gees acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT dooresk acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT baileyk acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT hazells acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT denauroisj acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT mossc acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT russellb acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT khanaa acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT rowleym acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT benjaminr acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT entingd acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT alrifaid acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT wuy acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT zhouy acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT barberp acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT ngt acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT spicerj acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT vanhemelrijckm acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT kumarm acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT vidlerj acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT lwiny acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT fieldsp acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT karagiannissn acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT coolenacc acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT rigga acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT papas acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT haydayac acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients
AT pattenpem acuteimmunesignaturesandtheirlegaciesinsevereacuterespiratorysyndromecoronavirus2infectedcancerpatients